Sherwood Forest slips on capital spend

FINANCE: Slippage on capital expenditure due to the delay on the renal scheme remains outside of the 25 per cent tolerance level that Monitor applies to capital spend variances.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here